Bio-Techne Corporation logo
Bio-Techne Corporation TECH
$ 58.55 0.06%

Quarterly report 2025-Q3
added 11-05-2025

report update icon

Bio-Techne Corporation Cash Conversion Cycle 2011-2025 | TECH

Annual Cash Conversion Cycle Bio-Techne Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
197 207 192 158 155 175 184 185 160 150 148 156 179 192 270

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
270 148 181

Quarterly Cash Conversion Cycle Bio-Techne Corporation

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
218 - 207 204 200 - 204 215 221 - 200 193 177 85.8 155 151 146 71.4 154 151 164 149 160 168 171 175 168 169 181 163 164 155 188 133 164 189 169 136 140 161 158 137 145 147 136 116 116 162 158 144 149 186 193 191 199 208 222 230 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
230 71.4 168

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
31.5 $ 4.93 4.78 % $ 818 M canadaCanada
Aclaris Therapeutics Aclaris Therapeutics
ACRS
-881 $ 3.2 -1.69 % $ 247 M usaUSA
Aptevo Therapeutics Aptevo Therapeutics
APVO
-47.4 $ 1.07 -5.75 % $ 295 K usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
17 - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
82.8 - -18.52 % $ 27.3 M britainBritain
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
25 - -15.15 % $ 60.3 M britainBritain
Albireo Pharma Albireo Pharma
ALBO
-1.55 K - -0.23 % $ 916 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-2.85 K - -11.43 % $ 502 K usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
166 $ 26.45 4.67 % $ 1.28 B usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
270 $ 9.6 0.37 % $ 141 M usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
391 $ 12.98 -7.91 % $ 854 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
946 - -6.81 % $ 3.04 B usaUSA
Axon Enterprise Axon Enterprise
AXON
86.2 $ 548.58 -2.78 % $ 41.6 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-2.15 K - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
174 $ 2.37 2.83 % $ 14.9 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
-58 $ 91.59 1.95 % $ 96.9 B britainBritain
Celldex Therapeutics Celldex Therapeutics
CLDX
-6.08 K $ 27.09 -1.53 % $ 1.74 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
117 - -24.86 % $ 820 K usaUSA
Brickell Biotech Brickell Biotech
BBI
149 - -5.38 % $ 6.06 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
49.5 - 0.49 % $ 251 B cayman-islandsCayman-islands
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
209 $ 11.33 -1.78 % $ 733 M usaUSA
Biogen Biogen
BIIB
387 $ 175.2 0.63 % $ 25.5 B usaUSA
Abeona Therapeutics Abeona Therapeutics
ABEO
387 $ 5.07 -5.5 % $ 108 M usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
-186 $ 87.67 -0.36 % $ 9.05 B usaUSA
ADiTx Therapeutics ADiTx Therapeutics
ADTX
-4.31 K $ 1.43 -36.18 % $ 18.8 K usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
6.09 - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
214 - -7.31 % $ 87 M usaUSA
Advaxis Advaxis
ADXS
-143 K - -9.65 % $ 45.9 M usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
54.2 $ 24.29 2.84 % $ 2.88 B usaUSA